Intellipharmaceutics International Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Intellipharmaceutics International Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending August 31, 2023 was $0.000.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 Aug 31, 2023 6-K 2023-10-16
Q2 2023 $334K May 31, 2023 6-K 2023-09-26
Q1 2023 $212K +$174K +466% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $602 +$602 Nov 30, 2022 20-F/A 2024-02-06
Q1 2022 $37.4K +$37.4K Feb 28, 2022 6-K 2022-04-14
Q4 2021 $0 -$566K -100% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $0 -$524K -100% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $119K -$121K -50.5% May 31, 2021 6-K 2021-07-15
Q1 2021 $0 -$264K -100% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $566K +$389K +220% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $524K +$428K +446% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $241K -$54.1K -18.4% May 31, 2020 6-K 2020-07-15
Q1 2020 $264K +$49.3K +22.9% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $177K -$61.9K -25.9% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $96K -$167K -63.5% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $295K -$151K -33.9% May 31, 2019 6-K 2019-07-10
Q1 2019 $215K Feb 28, 2019 6-K 2019-04-15
Q4 2018 $239K -$451K -65.3% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $263K Aug 31, 2018 6-K 2018-10-15
Q2 2018 $446K May 31, 2018 6-K/A 2018-07-24
Q4 2017 $690K Nov 30, 2017 6-K 2018-10-15
Q4 2015 $479K -$532K -52.7% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $1.01M -$465K -31.5% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $3.09M Feb 28, 2014 6-K 2014-04-14
Q4 2013 $1.48M +$1.47M +53023% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $2.78K -$605 -17.9% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $3.38K +$1.76K +109% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $1.62K Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.